Spin-off Companies in Biotech Acquisitions

This chapter explores the trend of creating separate stay-behind companies in biotech acquisitions through the example of Sanofi's acquisition of in-hipwrecks. It discusses the challenges and potential value of these spin-off companies, as well as competition in the genetic medicine space.